Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 13311-84-7 | Product Number: F0663
Flutamide

Purity: >98.0%(GC)
- 4'-Nitro-3'-(trifluoromethyl)isobutyranilide
- 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
5G |
$53.00
|
2 | Contact Us | ≥40 |
|
25G |
$134.00
|
1 | Contact Us | 15 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | F0663 |
Purity / Analysis Method | >98.0%(GC) |
Molecular Formula / Molecular Weight | C__1__1H__1__1F__3N__2O__3 = 276.22 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Condition to Avoid | Light Sensitive |
CAS RN | 13311-84-7 |
Reaxys Registry Number | 2157663 |
PubChem Substance ID | 87560202 |
Merck Index (14) | 4208 |
MDL Number | MFCD00072009 |
Appearance | White to Light yellow to Green powder to crystal |
Purity(GC) | min. 98.0 % |
Melting point | 110.0 to 114.0 °C |
Melting Point | 112 °C |
Solubility in water | Insoluble |
Solubility (soluble in) | Chloroform, Ether |
Pictogram |
![]() ![]() |
Signal Word | Danger |
Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. H370 : Causes damage to organs. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P307 + P311 : IF exposed: Call a POISON CENTER or doctor/ physician. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P362 : Take off contaminated clothing and wash before reuse. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
RTECS# | UG5700000 |
HS Number | 2924.29.7790 |
References
- Biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'-trifluoromethylisobutyranilide)
- Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
- Mechanism of action and pure antiandrogenic properties of flutamide
- Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
- Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer
- Flutamide. A review of methods of preparation, physical properties, stability, metabolism and pharmacokinetics and methods for the detection of flutamide
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.